Singapore designs preclinical model to strategise treatment for a genetic kidney disease
Tests using a preclinical model of Alport syndrome suggest that turning off a cell-signaling protein may significantly prolong life by preventing kidney scarring
United States Thomas Coffman Stuart Cook Journal Of The American Society Nephrology Cardiovascular Metabolic Disorders Programme American Society
Source: biospectrumasia.com